share_log

アステラス製薬:抗体-薬物複合体パドセブ 根治切除不能な尿路上皮癌に対する一次治療としてのペムブロリズマブとの併用療法について日本で適応追加に関する承認を取得

Astellas Pharma: Antibody-drug complex Padceb obtains approval for additional indications in Japan for combination therapy with pembrolizumab as primary treatment for unresectable urothelial cancer

JPX ·  Sep 24 02:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more